Geisinger, Healthy.io Clinical Trial Using Smartphones to Detect Kidney Disease | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Geisinger, Healthy.io Clinical Trial Using Smartphones to Detect Kidney Disease

April 11, 2018
by Heather Landi
| Reprints
Click To View Gallery

The National Kidney Foundation (NKF), Danville, Pa.-based health system Geisinger and Healthy.io have launched a clinical trial using a smartphone-enabled home urinalysis device for chronic kidney disease (CKD) among patients with high blood pressure.

Hypertension, or high blood pressure, is a contributing risk factor to CKD. One of the best ways to test for CKD and assess kidney damage is a simple urine test which detects the presence of albumin. The smartphone app from Healthy.io enables lay users to conduct a urinalysis test at home and securely share results with their clinicians, according to a Geisinger press release.

Healthy.io is a health technology company based in Tel Aviv, Israel that uses computer vision, machine learning and user-centric design to turn the smartphone camera into a clinical-grade medical device.

Approximately 30 million Americans have CKD, but nearly 90 percent do not know they have this condition. CKD progression can be slowed or halted if the disease, which often has no symptoms, is caught in its early stages, according to Geisinger officials.

“Early detection of CKD is crucial so that risk factors can be aggressively managed to prevent end-stage renal disease and cardiovascular disease,” Alexander Chang, M.D., practicing nephrologist and assistant professor in the Kidney Health Research Institute at Geisinger, said in a statement.

“This new trial using a smartphone app and urinalysis kit will provide important information on how to increase testing for CKD in this high-risk population,” Kerry Willis, Ph.D., chief scientific officer, NKF, said. “Our hope is that a home-based test makes it easier for patients at risk for CKD to comply with regular albuminuria screening, and that this will lead to earlier diagnosis and treatment of CKD, reducing cardiovascular risk and preserving kidney function.”  

The new trial will examine the effect of mailed, Healthy.io smartphone urinalysis kits (Dip.io test) to improve albuminuria screening compliance and detection of albuminuria and examine the feasibility of pharmacists in improving management of detected albuminuria, as pharmacists will be instructed to confirm test with urine albumin/creatinine ratio and treat albuminuria. 

What’s more, the clinical trial will also randomize 1,000 non-diabetic patients with hypertension who are receiving primary care at Geisinger. Patients will be randomized into two groups; one group receiving the usual care and one group who will receive a mailed Healthy.io urinalysis kit. A home test will be mailed to 500 Geisinger patients who have been diagnosed with hypertension, but who do not have diabetes, along with instructions for downloading the smartphone app, to determine if the patient also has CKD.

Geisinger patients will receive a letter and phone call educating them on the importance of screening for proteinuria from a team of nurses within the organization’s Care Gaps department. Appropriate follow-up will then be managed by the patient’s primary care provider and care team. 

“Healthy.io is proud to pioneer its 'adherence as a service’ platform with such forward-looking institutions as Geisinger and the National Kidney Foundation,” Yonatan Adiri, Healthy.io CEO, said in a statement. “Our mission is to use advanced computer vision and patient centric design to let clinicians empower their patients at scale without additional cost or effort. Like a Netflix for adherence we lean on the spread of digital technology and efficient logistics to offer on-demand testing delivered directly to the home. With a smartphone in your pocket, the point of care becomes wherever you are.” 

The new clinical trial, which gets underway this month, was announced April 10 at NKF’s 2018 Annual Spring Clinical Meetings held from April 10-14 at the Austin Convention Center, Texas.

 

The Health IT Summits gather 250+ healthcare leaders in cities across the U.S. to present important new insights, collaborate on ideas, and to have a little fun - Find a Summit Near You!


/news-item/mobile/geisinger-healthyio-clinical-trial-using-smartphones-detect-kidney-disease
/news-item/mobile/labcorp-joins-apple-health-records-project

LabCorp Joins Apple Health Records Project

November 5, 2018
by Rajiv Leventhal, Managing Editor
| Reprints

LabCorp, a provider of clinical laboratory and end-to-end drug development services, has announced that it has enabled Apple’s Health Records feature for its patients.

This iPhone feature aims to make it easier for LabCorp patients to access their LabCorp laboratory test results, along with other available medical data from multiple providers, whenever they choose, according to officials.

In January, Apple announced that it would be testing the Health Records feature out with 12 hospitals, inclusive of some of the most prominent healthcare institutions in the U.S. Since that time, more than 100 new organizations have joined the project,  according to Apple.

LabCorp test results are viewable in the Apple Health app for LabCorp patients who have an account with the company, and enable integration with the Health Records app. In addition to their LabCorp test results, patients will have information from participating healthcare institutions organized into one view, covering allergies, medical conditions, immunizations, lab results, medications, procedures and vitals.

Patients will receive notifications when their data is updated, and the Health Records data is encrypted and protected with the user’s iPhone passcode, Touch ID or Face ID, according to officials.

“LabCorp on Health Records will help provide healthcare consumers with a more holistic view of their health. Laboratory test results are central to medical decision making, and broadening access to this information will help patients take charge of their health and wellness, and lead to more informed dialogues between patients and their healthcare providers,” David P. King, chairman and CEO of LabCorp, said in a statement.

More From Healthcare Informatics

/news-item/mobile/himss-analytics-introduces-infrastructure-adoption-model-health-systems

HIMSS Analytics Introduces Infrastructure Adoption Model for Health Systems

October 25, 2018
by Rajiv Leventhal, Managing Editor
| Reprints

HIMSS Analytics, the research arm of the Healthcare Information and Management Systems Society, announced the introduction of the Infrastructure Adoption Model, or INFRAM, which is designed to measure the technical infrastructure used within a health system.

The INFRAM focuses on five technical subdomains, allowing organizations to benchmark how their infrastructure operates within the following areas: mobility; security; collaboration; transport; and data center.

Similar to HIMSS Analytics’ well-known Electronic Medical Record Adoption Model, or, EMRAM, the INFRAM is an eight-stage model (0 – 7) that allows healthcare IT leaders to map the technology infrastructure capabilities required to reach their facility’s clinical and operational goals, while meeting industry benchmarks and standards.  The final stage, Stage 7, guides organizations towards optimized information integration, contextualization and orchestration essential for the delivery of higher order local and virtualized care processes.

For reference purposes, Stage 0 on the model represents that an organization does not have a VPN, intrusion detection/prevention, security policy, data center or compute architecture. Stage 3 signifies that an organization has an advanced intrusion prevention system, while Stage 5 represents having video on mobile devices, location-based messaging, firewall with advanced malware protection, and real-time scanning of email hyperlinks.

HIMSS officials note that by identifying specific benchmarks for organizations to reach before they go live with EMR, systems, the INFRAM aims to ensure that a health system’s infrastructure is stable, manageable and extensible. Through this, organizations can ideally improve care delivery and create a pathway for infrastructure development tied to business and clinical outcomes.

 “The INFRAM is a welcome addition to our maturity model suite and addresses a longstanding need – guiding healthcare organizations in securely implementing the infrastructure with which their EMRs are built upon,” Blain Newton, executive vice president, HIMSS Analytics, said in a statement. “We have seen health systems engage with advanced clinical applications, only for them to ‘glitch’ under infrastructure that isn't powerful enough to support their tools. With the INFRAM, healthcare providers can develop a detailed, strategic technology plan that defines their organization's current state, desired future state, and each stage in between to achieve their clinical and operational goals.”

Related Insights For: Mobile

/webinar/clinical-team-communication-and-data-access-palm-your-hand

Clinical Team Communication and Data Access in the Palm of Your Hand

Thursday, October 25, 2018 | 1:00 p.m. ET, 12:00 p.m. CT

Eisenhower Health, a west coast-based Magnet Hospital, implemented an enterprise-wide solution enabling mobile communications and collaboration across all care teams, linking the entire enterprise, advancing its communications capabilities, creating access to an enterprise directory, and improving care team response and turnaround times.

Additionally, the system provided extensive and comprehensive reporting with data analytics showing where and to what extent response improvements were made, but also providing the information the hospital needed to better utilize the system and make adjustments to improve results.

See more on Mobile

betebettipobetngsbahis bahis siteleringsbahis